Are you sure you want to delete this post?
Washington Post, June 13, 2013: Supreme Court rules human genes may not be patented
In relation to the Myriad Genetics Inc.case before the court regarding their patent applications for the BRCA1 and BRCA2 genes that cause breast cancer.
"The Supreme Court ruled unanimously Thursday that human genes cannot be patented, a decision that could shape the future of medical and genetic research and have profound effects on pharmaceuticals and agriculture.
"Justice Clarence Thomas, writing for the court, said that merely isolating those specific genes — called BRCA1 and BRCA2 — was not worthy of a patent. “Myriad found the location of the BRCA1 and BRCA2 genes, but that discovery, by itself, does not render the BRCA genes . . . patent eligible,” Thomas wrote."
"On the other hand, Thomas wrote, Myriad’s creation of a synthetic form of DNA — called cDNA — based on its discovery does deserve patent protection."